NSABP Members' Area
Password Protected - Access
Limited to NSABP Participating
Institutions Only
NSABP Foundation, Inc.
General NSABP Information
Financial Conflicts of
Interest Policy
Coalition Comment:
Reconfiguration
IOM Report Group Comment
Contact the NSABP
Pathology Section
Future Meetings
NSABP Newsletters
Media Info on STAR
Employment
Clinical Trials Information
Clinical Trials Overview
Protocol Chart
Never Say Lost
Treatment Trials Information
Protocol B-39
Protocol B-43
Protocol B-47
Protocol B-49
Prevention Trials Information
Protocol P-1 - BCPT
Protocol P-2 - STAR
Protocol P-5
BreastCancerPrevention.com
Scientific Publications
Related Web Sites
Medical Search Engines
To report problems, ask
questions or make comments,
please send e-mail to:
Webmaster@nsabp.pitt.edu
Protocol B-47
A Randomized Phase III Trial of Adjuvant Therapy Comparing Chemotherapy Alone (Six Cycles of Docetaxel Plus Cyclophosphamide or Four Cycles of Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel) to Chemotherapy Plus Trastuzumab in Women with Node-Positive or High-Risk Node-Negative HER2-Low Invasive Breast Cancer
B-47 Contact List
B-47 Schema